Toll Free: 1-888-928-9744
Published: Feb, 2016 | Pages:
38 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Digna Biotech, S.L. - Product Pipeline Review - 2016 Summary Global Markets Direct's, 'Digna Biotech, S.L. - Product Pipeline Review - 2016', provides an overview of the Digna Biotech, S.L.'s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Digna Biotech, S.L., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the pipeline therapeutic landscape of Digna Biotech, S.L. - The report provides overview of Digna Biotech, S.L. including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses Digna Biotech, S.L.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features Digna Biotech, S.L.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects Reasons to Buy - Evaluate Digna Biotech, S.L.'s strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Digna Biotech, S.L. - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Digna Biotech, S.L.'s pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Digna Biotech, S.L. Snapshot 5 Digna Biotech, S.L. Overview 5 Key Information 5 Key Facts 5 Digna Biotech, S.L. - Research and Development Overview 6 Key Therapeutic Areas 6 Digna Biotech, S.L. - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Pipeline Products - Partnered Products 11 Partnered Products/Combination Treatment Modalities 12 Digna Biotech, S.L. - Pipeline Products Glance 13 Digna Biotech, S.L. - Clinical Stage Pipeline Products 13 Phase II Products/Combination Treatment Modalities 13 Phase I Products/Combination Treatment Modalities 14 Digna Biotech, S.L. - Early Stage Pipeline Products 15 Preclinical Products/Combination Treatment Modalities 15 Discovery Products/Combination Treatment Modalities 16 Digna Biotech, S.L. - Drug Profiles 17 Cardiotrophin-1 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 disitertide 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 Interferon Alfa-5 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 DB-017 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 DB-02901 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 DB-036 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 DB-039 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 DB-055 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 oncostatin M 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 DB-027 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 Digna Biotech, S.L. - Pipeline Analysis 30 Digna Biotech, S.L. - Pipeline Products by Target 30 Digna Biotech, S.L. - Pipeline Products by Route of Administration 31 Digna Biotech, S.L. - Pipeline Products by Molecule Type 32 Digna Biotech, S.L. - Pipeline Products by Mechanism of Action 33 Digna Biotech, S.L. - Recent Pipeline Updates 34 Digna Biotech, S.L. - Dormant Projects 35 Digna Biotech, S.L. - Locations And Subsidiaries 36 Head Office 36 Other Locations & Subsidiaries 36 Appendix 37 Methodology 37 Coverage 37 Secondary Research 37 Primary Research 37 Expert Panel Validation 37 Contact Us 37 Disclaimer 38
List of Tables Digna Biotech, S.L., Key Information 5 Digna Biotech, S.L., Key Facts 5 Digna Biotech, S.L. - Pipeline by Indication, 2016 7 Digna Biotech, S.L. - Pipeline by Stage of Development, 2016 9 Digna Biotech, S.L. - Monotherapy Products in Pipeline, 2016 10 Digna Biotech, S.L. - Partnered Products in Pipeline, 2016 11 Digna Biotech, S.L. - Partnered Products/ Combination Treatment Modalities, 2016 12 Digna Biotech, S.L. - Phase II, 2016 13 Digna Biotech, S.L. - Phase I, 2016 14 Digna Biotech, S.L. - Preclinical, 2016 15 Digna Biotech, S.L. - Discovery, 2016 16 Digna Biotech, S.L. - Pipeline by Target, 2016 30 Digna Biotech, S.L. - Pipeline by Route of Administration, 2016 31 Digna Biotech, S.L. - Pipeline by Molecule Type, 2016 32 Digna Biotech, S.L. - Pipeline Products by Mechanism of Action, 2016 33 Digna Biotech, S.L. - Recent Pipeline Updates, 2016 34 Digna Biotech, S.L. - Dormant Developmental Projects,2016 35 Digna Biotech, S.L., Other Locations 36 Digna Biotech, S.L., Subsidiaries 36
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.